Dr. Yutao Guo and Dr. Yazan Daaboul Discuss: A Report From The mAFA-II Trial Long-term Extension Cohort: Consumer-led Screening For Atrial Fibrillation April 3, 2022 Disclosures: TBA
Dr. Manesh Patel and Dr. C. Michael Gibson Discuss: PACIFIC AF: Multicenter, Randomized, Active Comparator-controlled, Double-blind, Double-dummy, Parallel Group, Dose-finding Phase 2 Study Comparing The Safety Of The Oral FXIa Inhibitor Asundexian With Apixaban In Patients With Atrial Fibrillation April 3, 2022 Disclosures: TBA
Dr. Florian Rader and Dr. C. Michael Gibson Discuss: Updated Cumulative Results Of Treatment With Mavacamten From The EXPLORER-LTE Cohort Of The MAVA-LTE Study In Patients With Obstructive Hypertrophic Cardiomyopathy April 3, 2022 Disclosures: TBA
Dr. Mark Loeb and Dr. C. Michael Gibson Discuss: IVVE: Randomized Controlled Trial Of Influenza Vaccine In Patients With Heart Failure To Reduce Adverse Vascular Events April 3, 2022 Disclosures: TBA
Dr. Javed Butler and Dr. C. Michael Gibson Discuss: DIAMOND Trial: Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications For Heart Failure With Reduced Ejection Fraction April 3, 2022 Disclosures: TBA
Dr. Gregory Lewis and Dr. C. Michael Gibson Discuss: METEORIC-HF: The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic Heart Failure And Reduced Ejection Fraction April 3, 2022 Disclosures: TBA
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: APOLLO Trial: Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial April 3, 2022 Disclosures: TBA
Dr. Lorenz Räber and Dr. Yazan Daaboul Discuss: PACMAN AMI: Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial April 3, 2022 Disclosures: TBA
Dr. Brian Bergmark and Dr. Yazan Daaboul Discuss: TRANSLATE-TIMI 70: Effect Of Vupanorsen On Non-high-density Lipoprotein Cholesterol Levels In Statin-treated Patients With Elevated Cholesterol April 3, 2022 Disclosures: TBA
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: ACC 2022 Wrap-Up – April 2, 2022 April 2, 2022 Disclosures: TBA
